ArticlePediatric endocrinology, diabetes, and metabolism2026
Comparison of somatic development, nutritional status, control of disease, and frequency of autoimmune comorbidities in Polish and Ukrainian children with type 1 diabetes.
Article in Pediatric endocrinology, diabetes, and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTe 1yp diabetes mellitus (DM1) requires lifelong insulin administration. Standards of care on children with DM1 may vary between countries. Since 2022, many war refugees from Ukraine with DM1 have continued treatment in Poland. AIM OF THE RESEARCH: To compare Polish (PL) and Ukrainian (UA) children with DM1 with respect to methods of insulin administration, glucose monitoring, auxological development, and comorbidities, and to re-assess UA children after 1 year of stay in Poland. MATERIAL AND
methodsThe retrospective analysis included 35 UA school-aged refugees and 70 PL children, matched with respect to sex, age, and DM1 duration.
resultsContinuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) were significantly more frequently used by PL children than by UA ones. Glycated hemoglobin (HbA1c) levels were lower in PL than in UA patients, in both CGM and CSII users. Patients' height standard deviation score (SDS) was significantly lower in UA than in PL children, while body mass index (BMI) SDS was significantly lower in UA patients on constant insulin doses. The incidence of overweight and obesity depended on the used centile charts (national for PL or UA children, or World Health Organization). After 1 year, more UA children used CSII and CGM, with an increase of height SDS and BMI SDS, while there was no effect on HbA1c. Vitamin D deficiency and autoimmune thyroiditis were common comorbidities.
conclusionsUse of CSII and especially of CGM is associated with improved DM1 control and auxological development. The migration of children with DM1 was associated with modification of their treatment and challenges in proper assessment of nutritional status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.